#obesity-drug-market

[ follow ]
#glp-1-medications #telehealth-partnerships #patent-litigation #business-turnaround #novo-nordisk #ozempic
Medicine
from24/7 Wall St.
2 months ago

Hims & Hers Surprise Rescue: Stock Explodes 40% on GLP-1 Truce

Novo Nordisk partners with Hims to distribute branded GLP-1 obesity medications after previously suing the telehealth provider, reversing a bitter legal dispute and restoring critical revenue for Hims.
Miscellaneous
from24/7 Wall St.
7 months ago

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Oct 2025)

Novo Nordisk's diabetes-origin drugs, notably Ozempic and Wegovy, have driven massive sales and company valuation, turning weight-loss effects into large profits.
[ Load more ]